SG11201704925WA - Hypochlorous acid formulations and methods for treating skin conditions - Google Patents

Hypochlorous acid formulations and methods for treating skin conditions

Info

Publication number
SG11201704925WA
SG11201704925WA SG11201704925WA SG11201704925WA SG11201704925WA SG 11201704925W A SG11201704925W A SG 11201704925WA SG 11201704925W A SG11201704925W A SG 11201704925WA SG 11201704925W A SG11201704925W A SG 11201704925WA SG 11201704925W A SG11201704925W A SG 11201704925WA
Authority
SG
Singapore
Prior art keywords
methods
hypochlorous acid
skin conditions
treating skin
acid formulations
Prior art date
Application number
SG11201704925WA
Other languages
English (en)
Inventor
Mark Sampson
Svetlana Pancheva
Cary Schockemoehl
Original Assignee
Realm Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/572,378 external-priority patent/US9381214B2/en
Priority claimed from US14/670,641 external-priority patent/US9999635B2/en
Application filed by Realm Therapeutics Inc filed Critical Realm Therapeutics Inc
Publication of SG11201704925WA publication Critical patent/SG11201704925WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201704925WA 2014-12-16 2015-12-16 Hypochlorous acid formulations and methods for treating skin conditions SG11201704925WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/572,378 US9381214B2 (en) 2011-03-18 2014-12-16 Methods for treating skin irritation
US14/670,641 US9999635B2 (en) 2007-01-16 2015-03-27 Methods and compositions for treating inflammatory disorders
PCT/US2015/066147 WO2016100543A2 (en) 2014-12-16 2015-12-16 Hypochlorous acid formulations and methods for treating skin conditions

Publications (1)

Publication Number Publication Date
SG11201704925WA true SG11201704925WA (en) 2017-07-28

Family

ID=56127847

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704925WA SG11201704925WA (en) 2014-12-16 2015-12-16 Hypochlorous acid formulations and methods for treating skin conditions

Country Status (12)

Country Link
US (1) US10987379B2 (de)
EP (1) EP3233091A4 (de)
JP (1) JP2017538755A (de)
KR (1) KR20170095312A (de)
CN (1) CN107206019B (de)
AU (1) AU2015364697A1 (de)
CA (1) CA2970804C (de)
HK (1) HK1245641A1 (de)
IL (1) IL252819A0 (de)
MX (1) MX2017007852A (de)
SG (1) SG11201704925WA (de)
WO (1) WO2016100543A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
WO2017127452A1 (en) * 2016-01-19 2017-07-27 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
WO2019006217A1 (en) 2017-06-28 2019-01-03 Collidion, Inc. COMPOSITIONS, METHODS AND USES FOR CLEANING, DISINFECTION AND / OR STERILIZATION
WO2019070920A1 (en) * 2017-10-03 2019-04-11 Collidion, Inc. COMPOSITIONS, METHODS AND USES FOR ENHANCING A ZONE OF SKIN OR HAIR
CN111801122B (zh) 2018-01-14 2023-06-02 科利迪恩公司 用于清洁、消毒、灭菌和/或治疗的组合物、试剂盒、方法和用途
AU2020298870A1 (en) * 2019-07-03 2022-02-24 Apr Applied Pharma Research, S.A. Therapeutic uses of oxidising hypotonic acid solutions
TWI774263B (zh) * 2021-03-11 2022-08-11 英屬維京群島商白因子國際股份有限公司 次氯酸組合物及其應用
CN115067353A (zh) * 2021-03-11 2022-09-20 英属维尔京群岛商白因子国际股份有限公司 次氯酸组合物及次氯酸凝胶的制作方法
CN113082050A (zh) * 2021-04-26 2021-07-09 贵州扬生医用器材有限公司 一种妇科用温敏凝胶及其制备方法
AU2022297975A1 (en) * 2021-06-25 2024-01-25 Ttd Global Pty Ltd Stabilised hypohalous acid solutions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355190B (en) * 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
JP5816406B2 (ja) 2005-03-23 2015-11-18 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を使用する皮膚潰瘍の治療方法
CA2637175C (en) 2006-01-20 2015-07-14 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
CN101405013A (zh) * 2006-01-20 2009-04-08 奥古露丝创新科学公司 使用氧化还原电位水溶液治疗或预防腹膜炎的方法
US20090305267A1 (en) 2006-05-03 2009-12-10 University Of Manitoba Microbial markers of inflammatory bowel disease
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
WO2008089268A2 (en) 2007-01-16 2008-07-24 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
US9381214B2 (en) * 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
WO2012129161A2 (en) 2011-03-18 2012-09-27 Puricore, Inc. Stabilized hypohalous acid solutions
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions

Also Published As

Publication number Publication date
MX2017007852A (es) 2018-01-11
CA2970804A1 (en) 2016-06-23
CN107206019B (zh) 2021-09-24
AU2015364697A1 (en) 2017-07-13
CN107206019A (zh) 2017-09-26
US10987379B2 (en) 2021-04-27
EP3233091A4 (de) 2018-07-18
WO2016100543A2 (en) 2016-06-23
US20200206263A1 (en) 2020-07-02
CA2970804C (en) 2023-01-31
HK1245641A1 (zh) 2018-08-31
IL252819A0 (en) 2017-08-31
EP3233091A2 (de) 2017-10-25
WO2016100543A3 (en) 2016-08-18
JP2017538755A (ja) 2017-12-28
KR20170095312A (ko) 2017-08-22

Similar Documents

Publication Publication Date Title
IL265590B (en) Formulations and methods for keratin treatment
HK1245641A1 (zh) 次氯酸製劑及治療皮膚病的方法
ZA201705673B (en) Methods for treating skin
IL252159B (en) Methods and formulations for the treatment of diseases of the blood vessels of the eye
IL246791A0 (en) Compositions and methods for treating eye diseases
EP3215219C0 (de) Hautbehandlungssystem
EP3139928A4 (de) Anordrin-zusammensetzungen und verfahren zur behandlung von krankheiten
HK1245127A1 (zh) 治療腦疾病的方法和組合物
ZA201701571B (en) Water treatment system and method
GB201410116D0 (en) Method of treatment
IL253028A0 (en) treatment method
EP3164132A4 (de) Verfahren und zusammensetzungen zur behandlung von erkrankungen und leiden
GB2530285B (en) Hydrophobic treatment for ski and method
EP3148556A4 (de) Hautbehandlungsformulierungen
HK1244782A1 (zh) 用於治療疾病和病癥的組合物和方法
GB2527046B (en) Device and method for the treatment of crops
ZA201802201B (en) Novel formulation and treatment methods
IL255012A0 (en) Preparations and methods for treating skin conditions
IL250244B (en) Prevention and treatment of inflammatory skin diseases
GB201404610D0 (en) Preparation and method for the treatment of skin
GB201421980D0 (en) Method of treatment
GB201421982D0 (en) Method of treatment
GB201415331D0 (en) Method of treatment
GB201414780D0 (en) Method Of Treatment